Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

SDĚLENÍ

Ministerstva zdravotnictví

ze xxx 20. listopadu 2014

x xxxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx pro rok 2015

Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx souvisejících xxxxxx, ve znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx pro xxx 2015:

1. Antiqenní složení xxxxxxxxxx látek pro xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx influenzae xxx b (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx xxxxxxxxxx xxx.

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx inactivatum xxxxx 1

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 2

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3

Xxxxxxxxxx Xxx: Polyribosylribitoli xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx anatoxinum

NEBO

1aa) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx záškrtu, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ b ( XXxXXxxXXXXXX)

Xxxxxxxxxxx anatoxinum

Tetani xxxxxxxxxx

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxxxxxxx xxxxxxxxxxxx

Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)

xxxxx 1 (Xxxxxxx)

xxxxx 2 (XXX-1)

xxxxx 3 (Xxxxxxx)

Xxxxxxxxx tegiminis xxxxxxxxxx X

Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)

xxxxxxxxx xxx xxxxxx xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), tetanu (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxxx vyvolaným Xxxxxxxxx xxxxxxxxxx b (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx ........................................... min. 30 mezinárodních xxxxxxxx

Xxxxxx xxxxxxxxxx .................................................... xxx. 40 mezinárodních jednotek

Pertussis xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (FHA) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx X ....................................... 10 xxxxxxxxxx

xxx anatoxino xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x:

1 dávka lyofilizované xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) očkovací látka xxxxx xxxxxx:

Xxxxxx anatoxinum ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X do 15 xxx věku:

Antigenum xxxxxxxxx xxxxxxxxxxx X .......................... 10 xxxxxxxxxx

1x) xxxxxxxx látka proti xxxxxx xxxxxxxxxx B xx 16 xxx x xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ........................... 20 mikrogramů

1h) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám:

Morbillorum xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx virus attenuatum (XXX 4385) xxx. 10^3,7 infekční dávka xxx buněčnou kulturu₅₀

Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) min. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu₅₀

1ch) xxxxxxxx látka xxxxx xxxxxx xxxxxxxx xxxxx x inaktivované xxxxx:

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ........... 40 antigenních X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (MEF-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx D xxxxxxxx*

* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx xxxxxx imunochemické xxxxxx.

1x) xxxxxxxx xxxxx proti xxxxxxx vyvolaným Streptococcus xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10A, 11 X, 12X, 14, 15X, 17F, 18X, 19X, 19X, 20, 22X, 23F, 33F ...... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx

1x) xxxxxxxx látka xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 3

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6B

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19F

Pneumococcale xxxxxxxxxxxxxxx sérotypus 23X

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx forma):

Diphtheriae xxxxxxxxxx ............................... ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx

Xxxxxx anatoxinum ........................................ xx xxxx xxx 20 mezinárodních xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx ... 8 mikrogramů

Pertaktin ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 D xxxxxxxx xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (kmen Xxxxxxx) ................................ 32 X xxxxxxxx xxxxxxxx

XXXX

1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (inaktivovaná xxxxx):

Xxxxxxxxxx toxoid ....................................... xxxx xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)

Xxxxxxxxx xxxxxx ....................................... více nebo xxxxx 20 mezinárodních xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx ................................ 2,5 mikrogramu

Filamentózní hemaglutinin ................. 5 mikrogramů

Fimbrie xxxx 2+3 ................................ 5 mikrogramů

Pertaktin ............................................. 3 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 1 (inaktivovaný) ... 40 xxxxxxxxxxx X jednotek

Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 xxxxxxxxxxx X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) ... 32 xxxxxxxxxxx X jednotek

1l) očkovací xxxxx proti tuberkulóze:

Mycobacterium xxxxx attenautum (XXX) xxxxxxx Danisuc 1331 ... 0,75 xx&xxxx;≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) očkovací xxxxx xxxxx xxxxxx hepatitidě X pro xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 xxxxx

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx

2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx dospělé:

Antigenum xxxxxxxxx xxxxxxxxxxx X 20 xxxxxxxxxx

2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx

Xxxxx xxxxxx xxxxxxxxxxx (xxxx Wistar xxxxxx XX/XX 38&xxxx;1503-3X xxxx nebo xxxxx 2,5 xxxxxxxxxxxxx jednotek x 1 xxxxx (0,5 xx)

2x) očkovací xxxxx proti xxxxxx xxxxxxxxxx X ve xxxxxxx xxx dospělé:

Hepatitis X xxxxx xxxxxxxxxxx

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx formuli xxx xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx xxx děti:

Virus xxxxxxxxx A xxxxxxxxxxx

X xxxx 2015 s xxxxxxx na xxxxxxxxxx xxxxxxxxxx vyhlášky č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, nelze xxxxxxxx případnou úpravu xxxxxxxxxxx xxxxxxx očkovacích xxxxx pro pravidelná xxxxxxxx xxxxxxxxxxxx nového xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx látek xx Xxxxxx zákonů.

Ministr:

MUDr. Xxxxxxx, XXX, x. x.

Informace

Právní xxxxxxx x. 278/2014 Xx. nabyl xxxxxxxxx dnem 13.12.2014.

Ke xxx uzávěrky právní xxxxxxx xxxxx měněn xx xxxxxxxxx.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.